2Xideas AG Sells 10,888 Shares of The Cooper Companies, Inc. $COO

2Xideas AG decreased its holdings in The Cooper Companies, Inc. (NASDAQ:COO) by 14.5% during the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 64,156 shares of the medical device company’s stock after selling 10,888 shares during the quarter. 2Xideas AG’s holdings in Cooper Companies were worth $4,399,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in the company. CYBER HORNET ETFs LLC bought a new position in shares of Cooper Companies in the second quarter valued at approximately $36,000. MUFG Securities EMEA plc purchased a new stake in Cooper Companies during the second quarter valued at about $42,000. Quent Capital LLC bought a new position in Cooper Companies during the third quarter worth about $44,000. Mather Group LLC. purchased a new position in shares of Cooper Companies in the third quarter worth about $56,000. Finally, Federated Hermes Inc. purchased a new position in shares of Cooper Companies in the third quarter worth about $58,000. Institutional investors own 24.39% of the company’s stock.

Insider Buying and Selling at Cooper Companies

In other Cooper Companies news, Director Lawrence Erik Kurzius purchased 2,000 shares of Cooper Companies stock in a transaction dated Wednesday, December 17th. The shares were acquired at an average cost of $82.50 per share, with a total value of $165,000.00. Following the completion of the transaction, the director owned 7,777 shares in the company, valued at approximately $641,602.50. This trade represents a 34.62% increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Holly R. Sheffield acquired 1,230 shares of the stock in a transaction dated Tuesday, December 16th. The shares were bought at an average price of $80.75 per share, with a total value of $99,322.50. Following the completion of the purchase, the insider directly owned 39,052 shares of the company’s stock, valued at approximately $3,153,449. This trade represents a 3.25% increase in their position. The SEC filing for this purchase provides additional information. In the last quarter, insiders bought 16,014 shares of company stock valued at $1,304,416. 2.08% of the stock is currently owned by corporate insiders.

Cooper Companies Trading Down 2.2%

Shares of COO opened at $69.92 on Friday. The firm has a market cap of $13.64 billion, a P/E ratio of 34.61, a price-to-earnings-growth ratio of 1.84 and a beta of 1.02. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.34 and a quick ratio of 0.79. The Cooper Companies, Inc. has a 1 year low of $61.78 and a 1 year high of $89.83. The company has a 50 day simple moving average of $81.23 and a two-hundred day simple moving average of $75.94.

Cooper Companies (NASDAQ:COO) last posted its earnings results on Thursday, March 5th. The medical device company reported $1.10 EPS for the quarter, beating analysts’ consensus estimates of $1.03 by $0.07. The firm had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $1.02 billion. Cooper Companies had a return on equity of 10.34% and a net margin of 9.67%.The company’s quarterly revenue was up 6.2% compared to the same quarter last year. During the same period in the prior year, the company earned $0.92 EPS. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. On average, equities analysts expect that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on COO. Citigroup cut their price objective on shares of Cooper Companies from $88.00 to $87.00 and set a “neutral” rating for the company in a research report on Friday, March 6th. KeyCorp reissued a “sector weight” rating on shares of Cooper Companies in a report on Friday, December 5th. Needham & Company LLC lifted their price target on Cooper Companies from $99.00 to $101.00 and gave the stock a “buy” rating in a research note on Friday, March 6th. The Goldman Sachs Group reiterated a “sell” rating and issued a $73.00 price objective on shares of Cooper Companies in a report on Friday, January 9th. Finally, Barclays raised their price objective on Cooper Companies from $98.00 to $103.00 and gave the company an “overweight” rating in a report on Friday, March 6th. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Cooper Companies presently has an average rating of “Moderate Buy” and an average price target of $90.79.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.